Structured evidence table for Sea Buckthorn Visual Performance Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Sea Buckthorn Visual Performance Meta-Analysis | Results Orexin-A reduced motion-induced behavioral abnormalities, nausea, and vomiting in rat and cat models. | 1 | Cai X (2025) | Orexin-A and motion sickness: a systematic review of animal model studies. |
| Sea Buckthorn Visual Performance Meta-Analysis | These benefits are likely mediated by the modulation of hypothalamic nuclei activity, enhanced stomach motility, and improved vestibular function. | 1 | Cai X (2025) | Orexin-A and motion sickness: a systematic review of animal model studies. |
| Sea Buckthorn Visual Performance Meta-Analysis | Conclusion Animal model studies indicates that orexin-A mitigates motion sickness (MS) symptoms in animal models, but overall certainty is low to moderate owing to risk of bias and indirectness. | 1 | Cai X (2025) | Orexin-A and motion sickness: a systematic review of animal model studies. |
| Sea Buckthorn Visual Performance Meta-Analysis | Background Sensory input mismatches among the vestibular system, autonomic control, and visual perception cause motion sickness. | 1 | Cai X (2025) | Orexin-A and motion sickness: a systematic review of animal model studies. |
Source documents